3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Malaria
1
Lymphoma, Follicular
1
Interventions
Fluticasone-Salmeterol Drug Combination
2
Fluticasone
2
Diclofenac
2
ziconotide
1
secukinumab
1
ropinirole
1
aliskiren
1
acetaminophen, codeine drug combination
1
Venlafaxine Hydrochloride
1
Thiotepa
1
Tacrolimus
1
Sublocade
1
Ribavirin
1
Radiotherapy
1
Quinine
1
Oxycodone
1
Naloxone
1
Ketamine
1
Furosemide
1
Filgrastim
1
Fentanyl
1
Escitalopram
1
Donepezil
1
Cyclophosphamide
1
Buprenorphine, Naloxone Drug Combination
1
Bimatoprost
1
Artesunate
1
Antilymphocyte Serum
1
Amoxicillin-Potassium Clavulanate Combination
1
Amlodipine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Lymphoma, Follicular
×
Artesunate
×
Clear all
NCT01805232
2013-03-06
IVAS
University of Khartoum
Phase 4
Unknown
80 enrolled